News Story: Full Text
Sponsored By
Gleolan for brain tumors
Please Click On The Above Banner For More Details
Braintumor Website


AstraZeneca Completes Enrollment in Phase III Non-Small Cell Lung Cancer Clinical Trial Program For IRESSA(R) (ZD1839) (PR Newswire)...Clinical studies are ongoing regarding the use of IRESSA for other solid tumors.......The National Cancer Institute (NCI) or oncology cooperative groups are accruing patients into clinical trials with IRESSA in renal cell, bladder, glioblastoma and brain cancers.......Expression and overexpression of EGFR is found in many tumor types and clinical data suggests that excessive levels of EGFR are linked to poor prognosis,...- May 08 10:38 AM ET

IF the story does not appear below, Click HERE to view the text of the story!
Note: The original website is displayed below - we have no control over it and are not responsible for the content of it, we just report it! IF you click on anything below, it will take you off of our website!
Original Source:

(Everything below this line is from!)

Click HERE to return to brain tumor news headlines

Home | Brain Tumor Guide | FAQs | Find A Treatment
Noteworthy Treatments | News | Virtual Trial | Videos | Novocure Optune® | Newsletter
Donations | Brain Tumor Centers | Survivor Stories | Temodar®
Fundraising For Research | Unsubscribe | Contact Us

Copyright (c) 1993 - 2020 by:
The Musella Foundation For Brain Tumor Research & Information, Inc
1100 Peninsula Blvd
Hewlett, NY 11557